2020
DOI: 10.1371/journal.pntd.0007939
|View full text |Cite
|
Sign up to set email alerts
|

Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice

Abstract: Cutaneous leishmaniasisis a vector-borne disease transmitted by Leishmania infected sand flies. PpSP15 is an immunogenic salivary protein from the sand fly Phlebotomus papatasi. Immunization with PpSP15 was shown to protect against Leishmania major infection. Lactococcus lactis is a safe non-pathogenic delivery system that can be used to express antigens in situ. Here, the codon-optimized Ppsp15-egfp gene was cloned in pNZ8121 vector downstream of the PrtP signal peptide that is responsible for expression and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 63 publications
0
10
0
Order By: Relevance
“…Notably, LJL-143 and LJM-17 were proposed as good vaccine candidates against canine Leishmaniasis caused by L. infantum, although an in vivo protective phenotype is yet to be demonstrated (Collin et al, 2009;Abbehusen et al, 2018). Additionally, from the saliva of the closely related P. duboscqui and P. papatasi sand flies, the homologous salivary proteins PpSP15 and PdSP15 (also known as PduM02) protected mice and non-human primates effectively from L. major-induced CL (Oliveira et al, 2008;Oliveira et al, 2015;Davarpanah et al, 2020). Three other proteins from the saliva of P. papatasi, PpSP36 (apyrase), PpSP42, and PpSP44 (both yellow-related proteins) were also proposed as good vaccine candidates for human CL (Tlili et al, 2018); however, efficacy results are either still missing, or contrary to this hypothesis in the case of PpSP44 in mice (Oliveira et al, 2008).…”
Section: Sand Fly Salivary Proteins As Anti-leishmania Vaccinesmentioning
confidence: 99%
See 1 more Smart Citation
“…Notably, LJL-143 and LJM-17 were proposed as good vaccine candidates against canine Leishmaniasis caused by L. infantum, although an in vivo protective phenotype is yet to be demonstrated (Collin et al, 2009;Abbehusen et al, 2018). Additionally, from the saliva of the closely related P. duboscqui and P. papatasi sand flies, the homologous salivary proteins PpSP15 and PdSP15 (also known as PduM02) protected mice and non-human primates effectively from L. major-induced CL (Oliveira et al, 2008;Oliveira et al, 2015;Davarpanah et al, 2020). Three other proteins from the saliva of P. papatasi, PpSP36 (apyrase), PpSP42, and PpSP44 (both yellow-related proteins) were also proposed as good vaccine candidates for human CL (Tlili et al, 2018); however, efficacy results are either still missing, or contrary to this hypothesis in the case of PpSP44 in mice (Oliveira et al, 2008).…”
Section: Sand Fly Salivary Proteins As Anti-leishmania Vaccinesmentioning
confidence: 99%
“…interferon-g, and IL-12)/low anti-inflammatory (e.g. IL-4, IL-10, TGF-) CD4+ T cell-induced cytokine responses Gomes et al, 2008;Oliveira et al, 2008;Collin et al, 2009;Tavares et al, 2011;Xu et al, 2011;de Moura et al, 2013;Abi Abdallah et al, 2014;Oliveira et al, 2015;Abbehusen et al, 2018;Cunha et al, 2018;Tlili et al, 2018;Gholami et al, 2019;Cecilio et al, 2020;Davarpanah et al, 2020).…”
Section: Sand Fly Salivary Proteins As Anti-leishmania Vaccinesmentioning
confidence: 99%
“…This recombinant strain have a great efficiency in inducing mucosal and systemic immune responses in chicken, against pathogenic avian influenza virus infection. Recently, alternative strategies to display the antigens at the L. lactis surface were developed, such as using a combination of Usp45 and the cA (C terminus of the peptidoglycan-biding domain) domain of the N-Acetyl-muraminidase [ 145 ], the Spax anchoring domain (Lei et al, 2020) or the PrtP signal peptide [ 161 ].…”
Section: Plasmid Vectors Available For Plasmid Dna and Recombinantmentioning
confidence: 99%
“…Moreover, L. lactismediated delivery of DNA vaccines also lead to the expression of post-translationally modified antigens by host cells resulting in presentation of conformationally restricted epitopes to the immune system for induction of both cellular and humoral immune responses [112]. Also, with the aforementioned properties, the last two decades witnesses the use of genetically engineered L. lactis system as effective oral based vaccine vehicles for delivering antigens of viruses, bacteria and parasites to elicit both systemic and mucosal immunity [155][156][157][158]. Finally, the size of PV1A and PV3B recombinant DNA (obtained after insertion of cDNA into pIL1 expression vector) was observed as 7477 bp and 8377 bp, respectively which lies inside the ORF and could be translated into respective protein sequences with four additional amino acids (MCKC) at the N-terminus (Fig.…”
Section: Codon Optimization In Silico Cloning and Expression Of Pv1a And Pv3bmentioning
confidence: 99%